Slide 1 Effectiveness of drug interventions to reduce nevirapine resistance after single-dose nevirapine as part of antiretroviral prophylaxis to prevent HIV mother-to-child…

Slide 1 Slide 2 Collecting Data on HIV Infection and Acting on it Dr Chisale Mhango FRCOG 1 NPC Training in MNH Slide 3 Objective The objective of this presentation is to…

Slide 1 Excellent healthcare – locally delivered Treatment 2013 Overview – Current global situation Tsitsi Apollo Zimbabwe Slide 2 9.7 million people on ART by end of…

Slide 1 Innovative rapid scale-up of effective PMTCT services to achieve virtual elimination of new pediatric HIV infections: A Zimbabwe experience Dr. Agnes Mahomva (MBChB,…

Resistances: The evidences The point of view of an epidemiologist PMTCT Programmes: What needs to change? MSF Expert Round Table - Geneva - June 23-24, 2008 Pr François…

PowerPoint Presentation Effectiveness of drug interventions to reduce nevirapine resistance after single-dose nevirapine as part of antiretroviral prophylaxis to prevent…

1. HIV PROPHYLAXIS FOLLOWING OCCUPATIONAL EXPOSURE What’s New – October 2012 UpdateSignificant revisions include the following:• The Medical Care Criteria Committee…

Annex 1. Survey results: strategies, tools and policies supporting the scaling up of treatment in 23 countries MSF field teams provided data for the first 16 countries shown…

lessons learned NACCAP 2004-2011: Foreword NACCAP Foreword EDCTP Introduction NACCAP Articles: APRIORI CoMMAL INTERACT ART-A EDCTP Articles: VITA PanACEA EDCTP-TB Networks…

HIV-1 subtype C now accounts for approximately 50% of the estimated 33 million people living with HIV/AIDS and half of the 1-2 million new infections annually. The predominance…